[Federal Register Volume 84, Number 99 (Wednesday, May 22, 2019)]
[Notices]
[Pages 23582-23583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10668]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: United States 
Pharmacopeial Convention

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before June 21, 2019. Such 
persons may also file a written request for a hearing on the 
application on or before June 21, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on March 
8, 2019, United States Pharmacopeial, 12601 Twinbrook Parkway, 
Rockville, Maryland 20852-1717 applied to be registered as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Methamphetamine..........................            1105  II
Cathinone................................            1235  I
Phenmetrazine............................            1631  II
Methylphenidate..........................            1724  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Methaqualone.............................            2565  I
Lysergic acid diethylamide...............            7315  I
4-Methyl-2,5-dimethoxyamphetamine........            7395  I
3,4-Methylenedioxyamphetamine............            7400  I
4-Methoxyamphetamine.....................            7411  I
Phencyclidine............................            7471  II
4-Anilino-N-phenethyl-4-piperidine (ANPP)            8333  II
Phenylacetone............................            8501  II
Alphaprodine.............................            9010  II
Anileridine..............................            9020  II
Cocaine..................................            9041  II
Codeine-N-oxide..........................            9053  I
Dihydrocodeine...........................            9120  II
Difenoxin................................            9168  I
Diphenoxylate............................            9170  II
Heroin...................................            9200  I
Levomethorphan...........................            9210  II
Levorphanol..............................            9220  II
Meperidine...............................            9230  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).

[[Page 23583]]

 
Morphine-N-oxide.........................            9307  I
Thebaine.................................            9333  II
Norlevorphanol...........................            9634  II
Oxymorphone..............................            9652  II
Noroxymorphone...........................            9668  II
Alfentanil...............................            9737  II
Sufentanil...............................            9740  II
------------------------------------------------------------------------

    The company plans to import the bulk control substances for 
distribution of analytical reference standards to its customers for 
analytical testing of raw materials.

    Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10668 Filed 5-21-19; 8:45 am]
 BILLING CODE 4410-09-P